Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satisfaction with Lactation Inhibition Methods
NCT04038749Unknown
- Sponsor
- Żelazna Medical Centre
- Start
- Jun 2019
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of bromocriptine and cabergoline in Agalactia (3 arms), sponsored by Żelazna Medical Centre. Primary endpoints: Visual Analogue Scale, Evaluation of breast status and 3 more. Status: unknown.
02
Drugs
bromocriptinecabergoline
03
Conditions
Agalactia
Beyond the preview
Go deeper on NCT04038749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04038749.